Predicate |
Object |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-505 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-24 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-137 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P25-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-506 |
filingDate |
2008-06-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationDate |
2010-09-09-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
JP-2010530422-A |
titleOfInvention |
Combination therapy for depression |
abstract |
Combination therapies for treating depressive disorders are provided herein. Combination therapy includes administering an effective amount of bupropion or a metabolite thereof together with at least one serotonin 5-HTIA partial agonist or metabolite thereof to a patient in need of treatment for a depressive disorder. Pharmaceutical formulations (including packaged pharmaceutical formulations) comprising this combination are also provided herein. |
priorityDate |
2007-06-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |